Dapagliflozin in PRESERVED Ejection Fraction Heart Failure
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mikhail Kosiborod, MD
Saint Luke's Mid America Heart Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heart Group of the Eastern Shore
Fairhope, Alabama, United States
- University of Southern California
Los Angeles, California, United States
- First Coast Cardiovascular Institute
Jacksonville, Florida, United States
- Charlotte Heart Group Research Center
Port Charlotte, Florida, United States
- Emory University
Atlanta, Georgia, United States
- Northshore University Healthsystem Research Insititute
Evanston, Illinois, United States
- Northwestern University
Evanston, Illinois, United States
- Chicago Medical Research
Hazel Crest, Illinois, United States
- Osf Healthcare Cardiovascular Institute
Peoria, Illinois, United States
- St. Vincent Cardiovascular Research Institute
Indianapolis, Indiana, United States
- Cotton O'Neil Clinical Research Center
Topeka, Kansas, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- Massachusetts Hospital
Boston, Massachusetts, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Saint Luke'S Mid America Heart Institute
Kansas City, Missouri, United States
- Washington University
St Louis, Missouri, United States
- Columbia University
New York, New York, United States
- St. Francis Hospital
New York, New York, United States
- Eastern Nephrology Associates
New Bern, North Carolina, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Allegheny Health Network Research Institute
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Baylor Scott and White Research Institute
Dallas, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Eastern Virginia Medical School
Norfolk, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Mar 2017
- Primary completion
- 13 Aug 2021
- Completion
- 13 Aug 2021
- Last update posted
- 19 Oct 2022
- Registered enrollment
- 324
- Registry id
- NCT03030235
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.